Israel Biotech Fund

Israel Biotech Fund

Israel Biotech Fund

Overview
Headquarters

Ruhrberg Science Center,Bell Entrance, 4th Floor,3 Pekeris Street Rabin Science Park,Rehovot, HaMerkaz 7670212

Type of Company

Private

Industries

Private Equity & Venture Capital
Investment Services & Portfolio Management

Executives & Employees

Co-Founder & General Partner

Co-Founder & General Partner

Co-Founder & General Partner

Analyst

Paths to Israel Biotech Fund
Potential Connections via
Relationship Science
You
Israel Biotech Fund
Investments
Details Hidden

Ayala Pharmaceuticals Ltd. is a company headquartered in Tel Aviv, Israel. The firm engages in developing targeted cancer therapies for people with genetically defined cancer. Roni Mamluk is the current CEO of the firm.The company says this about itself: Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. The company was founded in November 2017 with an experienced global management team and a strong investor base. The management bench recently expanded with the appointment of Andrea Vergara-Silva, M.D. as Chief Medical Officer. Ayala raised $17 million in a series A financing to fund the company's licensed product asset, Bristol-Myers Squibb BMS-906024 (now AL101), through a Phase 2 trial.

Details Hidden

Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.

Details Hidden

Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson's disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Israel Biotech Fund. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Israel Biotech Fund's profile does not indicate a business or promotional relationship of any kind between RelSci and Israel Biotech Fund.